Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis

Detalles Bibliográficos
Autores principales: Yang, Mingyang, Li, Toni, Jiang, Lihai, Wang, Yushu, Tran, Carolyn, Ao, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212623/
https://www.ncbi.nlm.nih.gov/pubmed/35728643
http://dx.doi.org/10.1016/j.jinf.2022.05.044
_version_ 1784730642447073280
author Yang, Mingyang
Li, Toni
Jiang, Lihai
Wang, Yushu
Tran, Carolyn
Ao, Guangyu
author_facet Yang, Mingyang
Li, Toni
Jiang, Lihai
Wang, Yushu
Tran, Carolyn
Ao, Guangyu
author_sort Yang, Mingyang
collection PubMed
description
format Online
Article
Text
id pubmed-9212623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92126232022-06-22 Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis Yang, Mingyang Li, Toni Jiang, Lihai Wang, Yushu Tran, Carolyn Ao, Guangyu J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-10 2022-06-18 /pmc/articles/PMC9212623/ /pubmed/35728643 http://dx.doi.org/10.1016/j.jinf.2022.05.044 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Yang, Mingyang
Li, Toni
Jiang, Lihai
Wang, Yushu
Tran, Carolyn
Ao, Guangyu
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title_full Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title_fullStr Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title_full_unstemmed Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title_short Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis
title_sort regdanvimab improves disease mortality and morbidity in patients with covid-19: a meta-analysis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212623/
https://www.ncbi.nlm.nih.gov/pubmed/35728643
http://dx.doi.org/10.1016/j.jinf.2022.05.044
work_keys_str_mv AT yangmingyang regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis
AT litoni regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis
AT jianglihai regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis
AT wangyushu regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis
AT trancarolyn regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis
AT aoguangyu regdanvimabimprovesdiseasemortalityandmorbidityinpatientswithcovid19ametaanalysis

Ejemplares similares